Home Reference intervals for iron-related blood parameters: results from a population-based cohort study (LIFE Child)
Article Open Access

Reference intervals for iron-related blood parameters: results from a population-based cohort study (LIFE Child)

  • Kristin Rieger , Mandy Vogel , Christoph Engel , Uta Ceglarek , Joachim Thiery , Jürgen Kratzsch , Kristian Harms , Fabian Glock , Andreas Hiemisch and Wieland Kiess EMAIL logo
Published/Copyright: May 16, 2016
Become an author with De Gruyter Brill

Abstract

Background: Pediatric reference intervals for iron-related parameters are determined continuously over time from a highly standardized sample collection by application of the R-package generalized additive models for location, scale and shape (GAMLSS), which is little known in laboratory medicine.

Methods: Two thousand seven hundred and seventy-eight samples from Leipzig research center for civilization diseases (LIFE) Child participants at the age of 2.5–19 years were analyzed on a Sysmex XN-9000 for hemoglobin and reticulocytes and on a Roche Cobas 8000 for transferrin and ferritin. Reference intervals were established by repeated model calculation by use of the LMS (λ-µ-σ) method from Cole with specifically weighted subsamples.

Results: Continuous and gender-specific reference intervals as well as smoothed percentile curves were established for hemoglobin, ferritin, reticulocytes and transferrin. In the case of repeated model calculations, single curves and averaged percentile curves were shown. The single curves outlined potential variations of the different parameter trends. The averaged percentile curves submitted a stable assessment of curve trends over time for iron-related parameters in childhood and adolescence.

Conclusions: For the first time current age- and gender- specific reference intervals are available by application of the R-package GAMLSS and the laboratory techniques applied here. Compared to earlier studies, previous findings can be completed and discrepancies related to different methodical approaches, can be pointed out. Relevant findings for the diagnosis of iron deficiency anemia, such as gender-dependent assessment of hemoglobin starting at the age of 11 instead of 15 [according to the World Health Organization (WHO)], are presented.

Reviewed Publication:

Bidlingmaier M. Kratzsch J.


Introduction

Iron represents in quantitative terms the most abundant essential trace element in people, and with enzymes dependent on it, is involved in important metabolic processes, such as oxygen binding and distribution via hemoglobin and myoglobin, transmitter production or cytokine induction. Inadequate iron intake can have many causes and manifests itself in a lack of iron, or even iron deficiency anemia, which is the most common form of anemia [1]. Clinically, it manifests itself in children early, unlike in adults, due to increased demand during growth. The symptoms are wide-ranging and may even include inhibition of physical, cognitive, mental and motor development [2, 3]. Contrary to outdated assumptions, iron deficiency anemia is detected not on the basis of a lowering of iron levels, but on the basis of a decrease in hemoglobin and ferritin concentrations, which are below the age-appropriate mean values by more than two standard deviations [4]. Latent iron deficiency may already be detected through a decrease in ferritin and an increase in transferrin levels while hemoglobin remains normal. A decreased reticulocyte count in addition to a drop in hemoglobin levels indicates a manifest iron deficiency [5, 6].

Reference intervals are used for the clinical interpretation of laboratory results and are thus the basis for clinical decisions. Particularly in pediatrics, age-related reference intervals are required to take adequate account of physical development, nutrition, growth, organ maturity, hormone and immune responses as well as diseases during specific age segments. After reference intervals had been used for iron-dependent parameters for a long time, which had been determined either several decades ago or on the basis of hospitalized test subjects, there have been a growing number of efforts in recent years to devise current reference intervals [7, 8]. These efforts have been informed by population-based data on children of different ages in the USA (NHANES, 1994; AACC, 2007) [911], Ireland (1997) [12], Canada (CALIPER, 2009/10/12) [1315], Germany (KiGGS, 2009 [16]; Zierk et al., 2013 [17]), Denmark (2012) [18] and Sweden (2013) [19]. Among the total of eight studies mentioned, reference intervals were specified for hemoglobin in six, for ferritin in four, for reticulocytes in two, and for transferrin in four of the studies. Furthermore, only the German studies have so far determined reference intervals for hemoglobin and ferritin in a continuous manner on the basis of age, including reference percentiles, rather than using age categories. There are still no continuous reference intervals for transferrin and reticulocytes. However, these parameters have until now been considered parameters with poorly confirmed information regarding reference intervals, a situation due to standardization deficits in measurement procedures as well as due to a lack of or poorly verified basic data, particularly with respect to children [20]. As a result of these gaps described, it is the objective of this paper to determine age- and gender-dependent reference intervals, including percentile curves, for the parameters hemoglobin, reticulocytes, ferritin and transferrin. This is done on the basis of a large study population by means of current and highly standardized laboratory methods as well as in applying the Generalized Additive Models for Location, Scale and Shape-R (GAMLSS-R) package, which is still relatively unknown in laboratory medicine.

Materials and methods

Study design and participants

The data of participants in the LIFE Child study, aged 2.5–19 years and from the region of Leipzig, have been used. LIFE Child is a sub-project of the “Leipzig Research Center for Civilization Diseases” of the University of Leipzig with a longitudinal/cross-sectional study design. The study received a positive assessment from the competent ethics commission (Reg. No. 264-10-19042010). At the beginning of each visit, the test subjects and their parents received information from a study physician before they had to sign a consent form, which was a requirement for participating in the study. The data of the test subjects were pseudonymized to prevent any conclusions about the individuals [21]. The participants were not part of a clinical cohort, in other words, the computation of reference intervals was primarily based on healthy children and adolescents. Only those measurement time points have been factored into the data analysis at which full readings were available for hemoglobin, ferritin, reticulocytes and transferrin. This yielded 2778 measurement time points of 1779 test subjects representing 1346 families. Figure 1 shows the age and gender composition of the random sample at each first measurement time point. As regards weight distribution, the majority of children (78%) had a normal weight, while 7% were underweight, 7% overweight, and 8% were considered obese. The average age-adjusted BMI was 0.1, with a minimum value of –4.6 and a maximum value of 4.8. As the age adjustment is based on references according to Kromeyer-Hauschild [22], the minor increase in the mean value can be attributed to the increasing trend of recent years that has seen children become more overweight. It was impossible to rule out that the parameters ferritin and transferrin were affected by potential infections, which is why the same calculations were done for this with the measurement time points of a simultaneous increase in CRP of ≥5 mg/L (n=84) being excluded. In general, the CRP increase was ≥2.8 to 5.0 mg/L in 5%, and ≥5.0 mg/L in 3% of the study participants. For 92% of the participants, the CRP level was within the reference interval. Furthermore, a medication-based iron uptake was documented at 0.4% of the measurement time points (n=10). These were not excluded due to their small number.

Figure 1: Histogram for age and gender distribution of the reference population from the LIFE Child cohort regarding the first visit (total: n=1779, boys: n=903, girls: n=876).
Figure 1:

Histogram for age and gender distribution of the reference population from the LIFE Child cohort regarding the first visit (total: n=1779, boys: n=903, girls: n=876).

Pre-analysis and analysis

Venous blood samples were taken at the beginning of a study day using EDTA whole blood and serum monovettes (Sarstedt AG & Co, Nümbrecht, Germany). The samples were then sent directly for instant analysis to the central laboratory in the same building. Observance of fasting times was attempted, but did not constitute an exclusion criterion if a participant did not comply. This decision was based on the fact that this was not required under either the German AWMF [23] guidelines on iron deficiency anemia or the World Health Organization (WHO) reports on assessing the iron status [24]. There was no indication of icteric, lipemic or hemolytic samples among the available study population. For the laboratory analysis of the full blood count (including reticulocytes), an automated XN series hematology analyzer for in-vitro diagnostics at the clinical laboratory of Sysmex Corporation (Sysmex XN-9000, Sysmex Deutschland GmbH, Norderstedt, Germany) was used. This device allows for the quantitative determination and analysis of the status quo and marks the detectable blood and body fluid components, especially for hemoglobin, using the sodium-lauryl-sulfate-hemoglobin method, and for reticulocytes, using fluorescence flow cytometry with semiconductor laser technology. Transferrin was analyzed by means of immunological turbidity tests using a cobas 8000 (c module), and ferritin by means of electrochemiluminescence immunoassays using a cobas 8000 (e module) (each one from Roche Diagnostics GmbH, Mannheim, Germany). The analytical test procedures were performed according to the manufacturer’s specifications. Only CE-IVD-certified tests approved for patients were used. By way of an example, the results of the daily quality control measurements of February 2014 were used to determine the interassay coefficients of variation. Relative to devices and target values, the interassay coefficient of variation for hemoglobin measurements was between 0.5% and 1.3% (target values 3.8/7.4/10.3 mmol/L, n=28–37, measured on three modules), for reticulocyte measurements between 2.3% and 5% (target values 50.4/23.4/8.9‰, n=28–37, measured on two modules), for ferritin measurements at 2.7% resp. 1.7% (target values 23.7 resp. 184 ng/mL, n=50 resp. 44), as well as for transferrin measurements at 2.4% (target values 2.01 resp. 3.28 g/L, n=47 resp. 40). The respective values were representatives of the other measurement periods; intra-assay coefficients of variations were not determined in the event of low interassay coefficients of variation.

Statistical analyses

The choice of statistical methodology was based on the IFCC guideline for establishing reference intervals [25] and on the WHO recommendations on the estimation of percentiles [26], which were worked out for anthropometric parameters, but are also increasingly used for other parameters. As recommended by the IFCC, the lower and upper reference values were the percentiles 2.5 and 97.5 [25]. A modified LMS (λ-μ-σ) method according to Cole, Rigby and Stasinopoulos taken from the WHO recommendations was used [27, 28], which is also implemented in the GAMLSS package of the statistics R software [2931]. This was used on the assumption of a Box-Cox power exponential distribution (BCPE), which can map normal distributions as well as steep and flat peaks, making it highly flexible. This way, it was possible to achieve a normalization of the age-based distribution, which is a requirement for determining reference intervals. These distributions are characterized by the parameters median (location parameter, μ, M), coefficient of variation (scale parameter, σ, S), skew (λ, L) and curvature (shape parameters) as a function of age [32, 33]. The approach of estimating the parameters as a continuous function of age was preferred, because it provided a better model for physiological development than a step-by-step consideration of different age intervals [27]. There were several measurement time points for each subject as a result of the longitudinal design. At the same time, the cohort consisted of 1346 families, some of whom participated with several children. To ensure the independence of the measuring points, as well as to be able to include all measuring points (and, thus, all information) in the model, a resampling technique was applied. Sub-samples were assigned in a first step by limiting the families to 600, followed by the selection of a measured value for each family. It was necessary to limit the number of families, because some families had only one measured value, and because the probability of factoring such a measured value into the calculation was to be <1. The sub-sample size of 600 values proved to be an acceptable subset in this case to allow for a maximum number of measured values while maintaining an adequate sampling selection. The sampling of a measured value per subject during multiple visits was congruent to the family sampling. The weightings were chosen in such way that all measured values were equally probable to be obtained. This was followed by the calculation of the respective models, done each time a thousand times on the basis of the sub-sample of 600 independent values. Figure 2 shows these calculations as gray individual curves. The average, estimated parameters (location, shape, scale) served as a basis for the calculation of the reference values, and are represented in Figure 2 as black curves. The smaller number of subjects in the outer age ranges made it necessary to limit the estimates to the age segment 3–16 years (total: n=2522, boys: n=1312, girls: n=1210). In order to be able to evaluate the effect that infections had on the parameters ferritin and transferrin, the calculations for these parameters were carried out also with an adjusted dataset that did not contain any measurement time points with a simultaneously increased CRP (≥5 mg/L) (total: n=2446, boys: n=1275, girls: n=1171). Moreover, PASW Statistics in Windows version 18.0 (SPSS Inc., Chicago, IL, USA) was used for further descriptive analysis.

Figure 2: Smoothed percentile curves of age (3–16 years) based on the reference population of LIFE Child cohort.The individual curves are gray and the averaged curves are black for the percentiles 2.5 (P 2.5), 10 (P 10), 50 (P 50), 90 (P 90), and 97.5 (P 97.5). (A) Hemoglobin curves (mmol/L) for boys. (B) Hemoglobin curves (mmol/L) for girls. (C) Ferritin curves (ng/mL) for boys. (D) Ferritin curves (ng/mL) for girls. (E) Reticulocyte curves (per 1000 erythrocytes) for boys. (F) Reticulocyte curves (per 1000 erythrocytes) for girls. (G) Transferrin curves (g/L) for boys. (H) Transferrin curves (g/L) for girls.
Figure 2:

Smoothed percentile curves of age (3–16 years) based on the reference population of LIFE Child cohort.

The individual curves are gray and the averaged curves are black for the percentiles 2.5 (P 2.5), 10 (P 10), 50 (P 50), 90 (P 90), and 97.5 (P 97.5). (A) Hemoglobin curves (mmol/L) for boys. (B) Hemoglobin curves (mmol/L) for girls. (C) Ferritin curves (ng/mL) for boys. (D) Ferritin curves (ng/mL) for girls. (E) Reticulocyte curves (per 1000 erythrocytes) for boys. (F) Reticulocyte curves (per 1000 erythrocytes) for girls. (G) Transferrin curves (g/L) for boys. (H) Transferrin curves (g/L) for girls.

Results

Using the adjusted statistical method (resampling) coupled with the GAMLSS package of the statistics R software, it was possible to create for the parameters hemoglobin, ferritin, transferrin, and reticulocytes reference intervals (percentiles 2.5 and 97.5) and smoothed percentile curves (percentiles 2.5, 10, 50, 90 and 97.5) continuously for age and separately for gender. Biannual base points of the respective parameters were calculated for the upper and lower reference limits (percentiles 2.5 and 97.5), the median (M), the coefficient of variation (S) and the skew (L) (summarized in the Table included in the Supplementry material). As a result of the statistical approach, and due to the 1000 calculations of the respective models, there were just as many individual curves that provided an overview of the potential fluctuations in the individual parameters. Furthermore, an averaging of these individual curves made it possible to realize a stable curve assessment. These curves are described in the following for each parameter.

The hemoglobin level rose, on average, from 7.5 mmol/L at age 3 to 8.3 mmol/L at age 11. A more pronounced gender-specific distribution became apparent from that age forward. This was characterized by a stagnation of the curves among the girls and a marked increase in the curves for the boys. The girls exhibited a constant median of 8.3 mmol/L, while the boys experienced an increase in the median to 9.3 mmol/L at the age of 16. By way of example, the reference intervals (P 2.5–P 97.5) ranged from 6.7 to 9.3 mmol/L for the boys and 6.8–8.9 mmol/L for the girls aged 3, from 7.3 to 9.3 mmol/L for the boys and 7.2–9.2 mmol/L for the girls aged 11, all the way to 7.9–10.4 mmol/L for the boys and 7.0–9.1 mmol/L for the girls aged 16 (Supplement, Table 1). A look at the individual hemoglobin curves revealed blurred upper limits (P 90, P 97.5) for children younger than 5 years, with more pronounced fluctuations among the boys than among the girls, as well as blurred lower limits (P 2.5) for the boys older than 15 years.

Ferritin exhibited, for the curves of percentiles 90 and 97.5, a reduction of the concentration (P 97.5) from 88.0 ng/mL for the boys and 87.2 ng/mL for the girls aged 3 years to 78.9 ng/mL for the boys and 75.8 ng/mL for the girls aged 6.5 years. Then, these curves showed a continuous increase up to the age of 16 years, which was more pronounced for boys upon reaching 128.4 ng/mL than it was for girls upon reaching 112.7 ng/mL. The curves for percentiles 2.5 and 10 remained largely constant across the ages, with the girls showing a slight downward trend from the age of 8 years with levels (P 2.5) from 16.6 ng/mL to 8.2 ng/mL at age 16. The 50th percentile curves for the boys increased slightly across the ages, from 29.7 ng/mL at age 3 to 45.7 ng/mL at age 16. For the girls, however, they remained largely unchanged between 33.81 and 35.91 ng/mL (Supplement, Table 2). The individual ferritin curves showed potential fluctuations in the upper limits (P 90, P 97.5) for both boys and girls across the entire age range. In addition, a sub-group (especially among the girls) began to take form. What manifested itself was a single curve grouping that exhibited across all percentile curves, but especially from the 50th percentile, significantly lower concentrations at age 3, increasing concentrations up to the age of 11, and a brief drop in concentrations followed by a virtually constant curve in contrast to the averaged curves. As ferritin is an acute-phase protein, all measurement time points where CRP was increased (≥5 mg/L) at the same time were also excluded from the calculation of percentiles. The estimated reference intervals differed from the values of the entire dataset with respect to the lower reference limit by a maximum of 0.7 ng/mL, and with respect to the upper reference limit, by a maximum of 6.5 ng/mL.

The relative reticulocyte content was constant across all the years of childhood and adolescence for the boys. The boys’ median was consistently between 9.1 and 9.2 per 1000 erythrocytes, with the reference interval (P 2.5–P 97.5) ranging from 4.7 to 5.0 to 15.7 and 16.0 per 1000 erythrocytes. The girls exhibited greater variability overall: the median was between 9.8 and 10.1 per 1000 erythrocytes and the reference interval (P 2.5–P 97.5) between 4.9 and 5.3–18.2 and 19.0 per 1000 erythrocytes (Supplement, Table 3). The upper limits (P 97.5) of the individual reticulocyte curves were blurred across the entire age range.

The transferrin concentrations, too, were overall constant across the ages. There was a slight increase in the curves of the percentiles 50, 90 and 97.5 for the girls. In total, however, the margin was minor. The median was between 2.7 and 3.0 g/L and the reference interval (P 2.5–P 97.5) between 2.2. and 2.3-3.2 and 4.0 g/L (Supplement, Table 4). The individual transferrin curves exhibited minor potential fluctuations in the upper (P 97.5) and lower limits (P 2.5) of the boys for the outer age ranges (under 5 years and over 13 years); for girls, this was the case only in the lower age ranges (under 5 years). As transferrin is an anti-acute-phase protein, all measurement time points where CRP was increased (≥5 mg/L) at the same time were also excluded from the calculation of percentiles. The estimated reference intervals did not differ from those of the entire dataset.

Discussion

The application of the LMS method according to Cole, which is integrated into the GAMLSS-R software package, may be considered an adequate method for estimating pediatric reference intervals. By applying the resampling method described, it is possible to include several measurement time points per subject and family, while also representing potential fluctuations as single curves, as well as stable curves by averaging the single curves. The curves can be represented in a continuous fashion across the ages, which is not only recommended by WHO [26], but also helps avoid the arbitrary division of age intervals and yields a better representation of physiological processes. The pediatric reference intervals for the parameters hemoglobin, ferritin, reticulocytes and transferrin were not previously worked out by means of the analyzers used in this context – Sysmex XN-9000 and Roche cobas 8000, c and e modules. This satisfies both the requirements of IFCC [25] to determine reference intervals in connection with new analytical methods and those of the manufacturers [34] regarding verification on the basis of one’s own reference population.

With the increase in concentrations up to the age of 11 years, as described, and the subsequent start of a gender-based progression characterized by relative constant concentrations in girls and a strong increase in boys, hemoglobin follows a typical trend confirmed by previous studies [10, 12, 17, 19, 35, 36]. This can generally be attributed to growth during childhood development. With the beginning of puberty, the differences can be explained on the basis of gender, particularly as a result of hormonal factors (erythropoietin stimulation due to androgens, or erythropoietin inhibition due to estrogens) and the onset of menstruation (blood loss) in girls. The studies of KiGGS [16] and Zierk et al. [17] lend themselves to comparison due to geographic proximity, timeliness and the description of continuous results. When comparing the reference intervals computed in this study with those of KiGGS (P 3–P 97), one sees mean deviations from the lower reference limits of 0.17 g/dL (maximum deviation: 0.38 g/dL) for boys and 0.07 g/dL (maximum deviation: 1.66 g/dL) for girls. As for the upper reference limits, one sees mean deviations of 0.66 g/dL (maximum deviation: 1.65 g/dL) for boys and 0.11 g/dL (maximum deviation: 1.76 g/dL) for girls. When comparing the reference intervals computed in this study with those of Zierk (P 2.5–P 97.5), one sees mean deviations from the lower reference limits of 0.34 g/dL (maximum deviation: 0.39 g/dL) for boys and 0.25 g/dL (maximum deviation: 0.7 g/dL) for girls. As for the upper reference limits, one sees mean deviations of 0.12 g/dL (maximum deviation: 1.15 g/dL) for boys and 0.19 g/dL (maximum deviation: 0.7 g/dL) for girls. Thus, the deviations from the studies mentioned are minor only. Any of the deviations are most likely attributable to the different analyzers used in the laboratory. It is virtually impossible for the generated measured values to harmonize perfectly due to the technical particulars of the different analyzers (different manufacturers, but also different models from a single manufacturer) [37]. As has been demonstrated, especially in the case of hemoglobin, the differences between various analyzers are minor compared to other hematological parameters [38]. Furthermore, differences can also be attributed to different criteria of inclusion and exclusion, as well as to the different statistical methods employed in the various studies.

Ferritin tends to be fairly constant in the lower percentiles (P 2.5, P 10), while the upper percentiles (P 90, P 97.5) are characterized by an increase that starts at the age of 6.5 years. The values increased more significantly in young males than in girls. Ferritin stores iron in the liver, bone marrow, spleen and other tissues, such as muscles. The increase in ferritin from the age of 6.5 years and the gender-specific differences are likely due to growth, organ maturation processes and hormonal changes, as well as the onset of menstruation in puberty. The calculation of percentiles to the exclusion of measurement time points with increased CRP yields virtually no deviations from the calculation that includes all measurement time points. This suggests that the statistical approach involving the estimate of the averaged percentile curves can compensate for pathological changes to some degree. A decision, therefore, was taken in favor of a larger data volume, that is, to show the entire dataset in Tables and Figures. When comparing the reference intervals computed in this study with those of KiGGS (P 3–P 97) [16], one sees mean deviations from the lower reference limits of 3.07 ng/mL (maximum deviation: 5.39 ng/mL) for boys and 4.07 ng/mL (maximum deviation: 6.22 ng/mL) for girls. As for the upper reference limits, one sees mean deviations of 25.25 ng/mL (maximum deviation: 42.27 ng/mL) for boys and 18.81 ng/mL (maximum deviation: 31.33 ng/mL) for girls. Comparability with other studies is limited because of the difference in the approach of continuous interval determination and the general separation by gender in this study, while other studies employed reference intervals mostly for age groups that were not consistently gender-specific. By contrast, however, the lower reference limits of the CALIPER study [14] were lower than those in the present study or those of the KiGGS study. One possible explanation could be the recruitment of hospitalized patients, for whom metabolic disorders had been ruled out, but who did include orthopedic patients, for example. In other words, clinical components might play a role here. In a US study done in 2004 [39], ferritin levels exhibited a greater variability that was associated with higher upper reference limits than those of the present study. Our study shows similar variability in the percentiles 2.5–97.5 only for adolescents. This, too, might be attributed to the fact that the aforementioned study used hospitalized patients as reference individuals. It is highly likely that the deviations mentioned can be explained by the difference in the recruitment of study populations. There are also indications that the use of different analyzers is instrumental in the discrepancy of findings also where ferritin is concerned [40].

If one uses the cut-off values for hemoglobin and ferritin issued by WHO [41] for diagnosing iron deficiency anemia as a basis for comparison, they harmonize with the results observed by us only partially, as they do with the results of the KiGGS [16] and Zierk et al. [17] studies. The WHO hemoglobin cut-off values are gender-specific only from the age of 15 years. But, as the current study shows, gender-specific differences manifest themselves already from the age of 11 years. Girls aged 12 and older generally remain below the WHO cut-off values according to the lower reference limits calculated in this study. When it comes to ferritin, this shortfall of the WHO cut-off values, when compared to this study and the KiGGS study, is even more significant and manifests itself already in girls aged 11. The WHO cut-off values for iron deficiency anemia diagnostics should, therefore, be updated.

The reticulocyte count remains largely constant across the entire age range, at 5–19 per 1000 erythrocytes, which is thus similar to a previously described margin of 5–15 per 1000 erythrocytes [35]. Previous data on reticulocyte counts have not been uniform. They are comparable only to a limited degree due to different representations as absolute and relative values. The literature has also described fluctuations due to different analyzers on multiple occasions [38, 42, 43]. Sysmex GmbH has described decreasing trends in adulthood [37], which partially matches the findings of this study. But, in contrast to the Sysmex references, this study has found lower lower reference limits and mostly higher upper reference limits, especially in girls. One Swedish study involving children aged between 8 and 18 years has demonstrated gender-specific differences, with higher concentrations in girls [19]. In the present study, this has been proved particularly with respect to the upper percentiles (P 50, P 90, P 97.5). The reticulocytes constitute the last immature precursor of the erythrocytes and will need to be re-created permanently to cover the breakdown of the erythrocytes. This is why a consistently equal share of reticulocytes is required under physiological conditions.

Transferrin is characterized by an overall continuous progression marked by an increase in variability among girls aged 12 and older. This has been confirmed by a large number of studies [1315, 18, 19], while the subject has been controversial in a few others [39, 44]. However, it bears mentioning that the changes occur in such a small margin that one cannot assume any relevant gender-specific difference. In other words, the reference intervals of different studies harmonize well. Transferrin acts as a transport protein that allows for the exchange of iron between the intestines, iron stores and erythroblasts. It responds to iron deficiency by way of an increase, but does not appear to be influenced directly by physiological development processes.

The potential fluctuations described for the single curves in the outer percentiles and outer age ranges reflect a reduced stability due to a smaller number of incoming measured values (only the outer 2.5%) as well as a lack of data points outside the outer age ranges that could act as reference points. But these two factors can be compensated for well by way the mean estimate of the single curves. The grouping of ferritin single curves, which has also been described, suggests that there is a sub-group with a common characteristic. The most likely explanation in this context is that this involves a genetic component, such as the representation of a specific ferritin type (isoferritin) [45, 46].

The analyses can yield current reference intervals for hemoglobin, ferritin, reticulocytes and transferrin in children and adolescents, based on a primarily healthy, highly standardized sample population. This has been done for the first time for the devices used, Sysmex XN-9000 and Roche cobas 8000 (c and e modules). The statistical GAMLSS R software package has been confirmed as an effective means to calculate percentile curves and reference intervals. The progressions of the parameters have been represented continuously across the ages, for the first time for reticulocytes and transferrin, rather than on the basis of age groups. This approach maps physiological conditions (smooth transitions instead of stepwise approach) and prevents the problem of an arbitrary classification of age intervals. Furthermore, the customized statistical method has presented a way in which a longitudinal design can be applied to a cross-sectional study. In addition, it is possible to include family members, without violating the independence necessary for the calculations. The repeated model computations and averaging of the resulting single curves increase reliability and move the influence of confounders, CRP increases in this case, to the background. The individual curves further allow for potential fluctuations or special characteristics, such as the ferritin sub-group described, to be evaluated. By working out agreements and deviations with respect to other studies, factors, such as analyzers, criteria of inclusion and exclusion, type of age (continuous or grouped) and gender analysis (separated by gender or collectively), clinical aspects and statistical methodology, as well as the IFCC recommendation on the regular revision of reference intervals can be substantiated. Our study draws attention particularly to a possible revision of the WHO reference intervals for hemoglobin and ferritin.

Acknowledgments:

This publication was funded by LIFE-Leipzig Research Center for Civilization Diseases. LIFE is funded by the European Union through the European Regional Development Fund (ERDF) and by the Free State of Saxony under the State Excellence Initiative. This is an interdisciplinary project. The data analysis and production of the manuscript were done by K. Rieger in collaboration with M. Vogel and C. Engel with respect to statistics; with U. Ceglarek, J. Thiery, J. Kratzsch and K. Harms with respect to laboratory medicine; with F. Glock, A. Hiemisch and W. Kiess with respect to pediatrics. We would like to express our gratitude for this excellent cooperation.

  1. Author contribution: All authors are responsible for the entire contents of this article and have approved the submission of the manuscript.

  2. Research funding: LIFE – Leipzig Research Center for Civilization Diseases, funded by the European Union through the European Regional Development Fund (ERDF) and by the Free State of Saxony under the State Excellence Initiative

  3. Conflict of interest: The authors state that there are no economic or personal conflicts of interest. All tests done on human subjects described herein have been carried out with the consent of the competent Ethics Committee (Reg. No. 264-10-19042010), in accordance with national law, and the 1975 Declaration of Helsinki (in the current, amended version). All test subjects involved have signed a consent form.

References

1. World Health Organization. Prevalence and epidemiology of iron deficiency. In: Iron deficiency anaemia. Assessment, prevention, and control: a guide for programme managers. Geneva: WHO, 2001:15–7.Search in Google Scholar

2. World Health Organization. Functional consequences of iron deficiency. In: Iron deficiency anaemia. Assessment, prevention, and control: a guide for programme managers. Geneva: WHO, 2001:7–10.Search in Google Scholar

3. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG. Iron deficiency and cognitive achievement among schoolaged children and adolescents in the United States. Pediatrics 2001;107:1381–6.10.1542/peds.107.6.1381Search in Google Scholar PubMed

4. Kunz JB, Kulozik AE. Differenzialdiagnose der kindlichen Anämie. Monatsschr Kinderheilkd 2012;160:395–406.10.1007/s00112-012-2624-6Search in Google Scholar

5. Nielsen P, Gaedicke G. Physiologie und Pathophysiologie des Eisenstoffwechsels. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J (Hrsg). Pädiatrische Hämatologie und Onkologie. Berlin: Springer, 2006:101–10.10.1007/3-540-29036-2_7Search in Google Scholar

6. DeLoughery TG. Microcytic anemia. N Engl J Med 2014;371: 1324–31.10.1056/NEJMra1215361Search in Google Scholar PubMed

7. Schnabl K, Chan MK, Adeli K. Pediatric reference intervals: critical gap analysis and establishment of a national initiative. Clin Biochem 2006;39:559–60.10.1016/j.clinbiochem.2006.03.009Search in Google Scholar PubMed

8. Kohse KP. National and international initiatives and approaches for the establishment of reference intervals in pediatric laboratory medicine. LaboratoriumsMedizin 2015;39:197–212.10.1515/labmed-2015-0055Search in Google Scholar

9. National health and nutrition examination survey, 1976–80. Bethesda, MD: National Center for Health Statistics, 1982.Search in Google Scholar

10. National Health and Nutrition Examination Survey, III, 1988-94. Public use data, Rev. Oct. 1997. NCHS CD-ROM. Series 11, no. 1. Hyattsville, MD:U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 1997.Search in Google Scholar

11. Soldin SJ, Brugnara C, Wong EC. Pediatric reference intervals, 6th ed. Washington, DC: AACC Press, 2007.Search in Google Scholar

12. Taylor MR, Holland CV, Spencer R, Jackson JF, O’Connor GI, O’Donnell JR. Haematological reference ranges for schoolchildren. Clin Lab Haematol, 1997;19:1–15.10.1046/j.1365-2257.1997.00204.xSearch in Google Scholar PubMed

13. Chan MK, Seiden-Long I, Aytekin M, Quinn F, Ravalico T, Ambruster D, et al. Canadian Laboratory Initiative on Pediatric Reference Interval Database (CALIPER): pediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin Biochem 2009;42:885–91.10.1016/j.clinbiochem.2009.01.014Search in Google Scholar PubMed

14. Blasutig IM, Jung B, Kulasingam V, Baradaran S, Chen Y, Chan MK, et al. Analytical evaluation of the VITROS 5600 Integrated System in a pediatric setting and determination of pediatric reference intervals. Clin Biochem 2010;43:1039–44.10.1016/j.clinbiochem.2010.05.011Search in Google Scholar PubMed

15. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68.10.1373/clinchem.2011.177741Search in Google Scholar PubMed

16. Dortschy R, Schaffrath Rosario A, Scheidt-Nave C, Thierfelder W, Thamm M, Gutsche J, et al. Ergebnisse. In: Robert-Koch-Institut (Hrsg). Bevölkerungsbezogene Verteilungswerte ausgewählter Laborparameter aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS). Berlin: Robert-Koch-Inst, 2009:11–45.Search in Google Scholar

17. Zierk J, Arzideh F, Haeckel R, Rascher W, Rauh M, Metzler M. Indirect determination of pediatric blood count reference intervals. Clin Chem Lab Med 2013;51:863–72.10.1515/cclm-2012-0684Search in Google Scholar PubMed

18. Hilsted L, Rustad P, Aksglaede L, Sorensen K, Juul A. Recommended Nordic paediatric reference intervals for 21 common biochemical properties. Scand J Clin Lab Invest 2013;73:1–9.10.3109/00365513.2012.721519Search in Google Scholar PubMed

19. Aldrimer M, Ridefelt P, Rödöö P, Niklasson F, Gustafsson J, Hellberg D. Population-based pediatric reference intervals for hematology, iron and transferrin. Scand J Clin Lab Invest 2013;73:253–61.10.3109/00365513.2013.769625Search in Google Scholar PubMed

20. Thierfelder W, Dortschy R, Hintzpeter B, Kahl H, Scheidt-Nave C. Biochemische Messparameter im Kinder- und Jugendgesundheitssurvey (KiGGS) [Biochemical measures in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundhbl Gesundheitsforsch Gesundheitsschutz 2007;50:757–70.10.1007/s00103-007-0238-2Search in Google Scholar PubMed

21. Quante M, Hesse M, Döhnert M, Fuchs M, Hirsch C, Sergeyev E, et al. The LIFE child study: a life course approach to disease and health. BMC Public Health 2012;12:1021–34.10.1186/1471-2458-12-1021Search in Google Scholar PubMed PubMed Central

22. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß, HC, Hesse V, et al. Perzentile für den Body-mass-Index für das Kindesund Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001;149:807–18.10.1007/s001120170107Search in Google Scholar

23. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. Langfassung der Leitlinie „Eisenmangelanämie“. Available at: http://www.awmf.org/leitlinien/detail/ll/025-021.html. Accessed: 31. August 2015.Search in Google Scholar

24. World Health Organization, Centers for Disease Control and Prevention. Assessing the iron status of populations. Second edition, including literature reviews. Geneva, [Atlanta, GA]: World Health Organization, Department of Nutrition for Health and Development; Centers for Disease Control and Prevention, Division of Nutrition and Physical Activity, International Micronutrient Malnutrition Prevention and Control Program, 2007.Search in Google Scholar

25. Horowitz GL. Defining, establishing, and verifying reference intervals in the clinical laboratory. Approved guideline, 3rd ed. Clinical and Laboratory Standards Institute, C28-A3 = v. 28, no. 30. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.Search in Google Scholar

26. Borghi E, Onis M de, Garza C, Van den Broeck J, Frongillo EA, Grummer-Strawn L, et al. Construction of the World Health Organization child growth standards: selection of methods for attained growth curves. Stat Med 2006;25:247–65.10.1002/sim.2227Search in Google Scholar PubMed

27. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305–19.10.1002/sim.4780111005Search in Google Scholar PubMed

28. Cole TJ, Stanojevic S, Stocks J, Coates AL, Hankinson JL, Wade AM. Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood. Stat Med 2009;28:880–98.10.1002/sim.3504Search in Google Scholar PubMed PubMed Central

29. R Core Team. R: A Language and Environment for Statistical Computing. Available at: http://www.R-project.org/.Search in Google Scholar

30. Rigby RA, Stasinopoulos DM. Generalized additive models for location, scale and shape, (with discussion). J R Stat Soc Ser C Appl Stat 2005;54:507–54.10.1111/j.1467-9876.2005.00510.xSearch in Google Scholar

31. Stasinopoulos DM, Rigby RA. Generalized additive models for location, scale and shape (GAMLSS) for modeling reference. J Stat Softw 2007;23:1–46.10.18637/jss.v023.i07Search in Google Scholar

32. Box GEP, Cox DR. An analysis of transformation. J R Stat Soc Series B Stat Methodol 1964:211–52.10.1111/j.2517-6161.1964.tb00553.xSearch in Google Scholar

33. Rigby RA, Stasinopoulos DM. Smooth centile curves for skew and kurtotic data modelled using the Box-Cox power exponential distribution. Stat Med 2004;23:3053–76.10.1002/sim.1861Search in Google Scholar PubMed

34. Sysmex Deutschland GmbH. „Referenzwerte“ – Haben Sie da etwas von Sysmex? Available at: http://www.sysmex.de/akademie/wissenszentrum/haematologie/referenzbereiche.html. Accessed: 29.11.2015.Search in Google Scholar

35. Heil W, Ehrhardt V. Reference ranges for adults and children: pre-analytical considerations. Mannheim: Roche Diagnostics GmbH, 2008.Search in Google Scholar

36. Sysmex Austria GmbH. Pädiatrische Referenzintervalle für das Analysensystem Sysmex XE-2100. Available at: http://www.sysmex.de/fileadmin/media/f101/Xtra/Themenblaetter/14.1.05_Paediatrische_Referenzintervalle_RZ_Web.pdf. Accessed:29.11.2015.Search in Google Scholar

37. Sysmex Deutschland GmbH. Die Erythrozytenindices. Available at: http://www.sysmex.ch/fileadmin/media/f114/Xtra/Themenblaetter/Die_Erythrozytenindizes_-_Xtra_Schweiz_Fruehjahr_2013.pdf. Accessed: 29.11.2015.Search in Google Scholar

38. Bruegel M, Nagel D, Funk M, Fuhrmann P, Zander J, Teupser D. Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000. Clin Chem Lab Med 2015;53:1057–71.10.1515/cclm-2014-0945Search in Google Scholar PubMed

39. Soldin OP, Bierbower LH, Choi JJ, Choi JJ, Thompson-Hoffman S, Soldin SJ. Serum iron, ferritin, transferrin, total iron binding capacity, hs-CRP, LDL cholesterol and magnesium in children; new reference intervals using the Dade Dimension Clinical Chemistry System. Clin Chim Acta 2004;342:211–7.10.1016/j.cccn.2004.01.002Search in Google Scholar PubMed PubMed Central

40. Zhang X, Lu Y, Ma L, Peng Q, Qin X, Li S. A comparison study between two analyzers for determining serum ferritin. Clin Lab 2015;61:169–74.10.7754/Clin.Lab.2014.140807Search in Google Scholar PubMed

41. World Health Organization. Methods of assessing iron status. In: World Health Organization (Hrsg). Iron deficiency anaemia. Assessment, prevention, and control: a guide for programme managers. Geneva: WHO, 2001:33–8.Search in Google Scholar

42. d’Onofrio G, Kim YR, Schulze S, Lorentz T, Dorner K, Goossens W, et al. Evaluation of the Abbott Cell Dyn 4000 automated fluorescent reticulocyte measurements: comparison with manual, FACScan and Sysmex R1000 methods. Clin Lab Haematol 1997;19:253–60.10.1046/j.1365-2257.1997.00078.xSearch in Google Scholar PubMed

43. Van den Bossche J, Devreese K, Malfait R, Van de Vyvere, M, Schouwer P de. Comparison of the reticulocyte mode of the Abx Pentra 120 Retic, Coulter General-S, Sysmex SE 9500, Abbott CD 4000 and Bayer Advia 120 haematology analysers in a simultaneous evaluation. Clin Lab Haematol 2001;23:355–60.10.1046/j.1365-2257.2001.00420.xSearch in Google Scholar PubMed

44. Lockitch G, Halstead AC, Wadsworth L, Quigley G, Reston L, Jacobson B. Age- and sex-specific pediatric reference intervals and correlations for zinc, copper, selenium, iron, vitamins A and E, and related proteins. Clin Chem 1988;34:1625–8.10.1093/clinchem/34.8.1625Search in Google Scholar

45. Powell LW, Alpert E, Isselbacher KJ, Drysdale JW. Human isoferritins: organ specific iron and apoferritin distribution. Br J Haematol 1975;30:47–55.10.1111/j.1365-2141.1975.tb00516.xSearch in Google Scholar PubMed

46. McKeering LV, Halliday JW, Caffin JA, Mack U, Powell LW. Immunological detection of isoferritins in normal human serum and tissue. Clin Chim Acta 1976;67:189–97.10.1016/0009-8981(76)90259-XSearch in Google Scholar


Article note:

The original German online version at: http://www.degruyter.com/view/j/labm.2016.40.issue-1/labmed-2015-0093/labmed-2015-0093.xml?format=INT. The German article was translated by Compuscript Ltd. and authorized by the authors.



Supplemental Material:

The online version of this article (DOI: 10.1515/labmed-2016-0019) offers supplementary material, available to authorized users.


Received: 2015-10-21
Accepted: 2016-1-4
Published Online: 2016-5-16

©2016 by De Gruyter

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Downloaded on 29.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/labmed-2016-0019/html
Scroll to top button